Virpax Pharmaceuticals Files 8-K with Corporate Updates
| Field | Detail |
|---|---|
| Company | Virpax Pharmaceuticals, Inc. |
| Form Type | 8-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, financials, amendment
TL;DR
Virpax Pharma filed an 8-K on 3/21/25 for corporate updates and financials.
AI Summary
Virpax Pharmaceuticals, Inc. filed an 8-K on March 21, 2025, reporting amendments to its Articles of Incorporation or Bylaws and filing financial statements and exhibits. The company, incorporated in Delaware with its principal executive offices in Berwyn, PA, is in the pharmaceutical preparations industry.
Why It Matters
This filing indicates corporate housekeeping and the submission of financial documents, which are standard procedures for public companies and provide transparency to investors.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse events.
Key Players & Entities
- Virpax Pharmaceuticals, Inc. (company) — Registrant
- March 21, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- Berwyn, PA (location) — Principal Executive Offices
FAQ
What specific amendments were made to Virpax Pharmaceuticals' Articles of Incorporation or Bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary information.
What financial statements and exhibits are being filed with this 8-K?
The filing states that Financial Statements and Exhibits are being filed, but the specific content of these documents is not detailed in the provided text.
When was Virpax Pharmaceuticals, Inc. incorporated?
Virpax Pharmaceuticals, Inc. was incorporated in Delaware.
What is the principal executive office address for Virpax Pharmaceuticals, Inc.?
The principal executive offices are located at 1055 Westlakes Drive, Suite 300, Berwyn, PA 19312.
What is the SIC code for Virpax Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Virpax Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding Virpax Pharmaceuticals, Inc..